Showing results (141-150 of 156) with videos related to
Sort By:
Pageof 16
European Journal of Nuclear Medicine and Molecular Imaging|June 22, 2026
Evaluation of [¹⁸F]AlF-NOTA-octreotide PET/CT in routine clinical use: a retrospective analysis in 288 neuroendocrine tumor patientsHannes Leupe, Sophie-Anne De Buyst, Jeroen Dekervel, et al.The Lancet. Oncology|October 11, 2018
Use of modern imaging methods to facilitate trials of metastasis-directed therapy for oligometastatic disease in prostate cancer: a consensus recommendation from the EORTC Imaging GroupFrédéric E Lecouvet, Daniela E Oprea-Lager, Yan Liu, et al.European Radiology|May 7, 2025
Multicollinearity and redundancy of the PET radiomic feature setWyanne A Noortman, Dennis Vriens, Johan Bussink, et al.European Journal of Nuclear Medicine and Molecular Imaging|June 19, 2024
Joint EANM/EANO/RANO/SNMMI practice guideline/procedure standards for diagnostics and therapy (theranostics) of meningiomas using radiolabeled somatostatin receptor ligands: version 1.0Nathalie L Albert, Matthias Preusser, Tatjana Traub-Weidinger, et al.Cancers|June 22, 2023
Development and External Validation of a PET Radiomic Model for Prognostication of Head and Neck CancerWyanne A Noortman, Nicolas Aide, Dennis Vriens, et al.Journal of Neuroendocrinology|December 14, 2023
Use and perceived utility of [18 F]FDG PET/CT in neuroendocrine neoplasms: A consensus report from the European Neuroendocrine Tumor Society (ENETS) Advisory Board Meeting 2022Valentina Ambrosini, Martyn Caplin, Justo P Castaño, et al.Journal of Neuroendocrinology|May 16, 2024
Clinical management of typical and atypical carcinoids/neuroendocrine tumors in ENETS centres of excellence (CoE): Survey from the ENETS lung NET task forceAnna Koumarianou, Pier Luigi Filosso, Lisa Bodei, et al.Journal of Neuroendocrinology|December 9, 2024
Challenges in developing response evaluation criteria for peptide receptor radionuclide therapy: A consensus report from the European Neuroendocrine Tumor Society Advisory Board Meeting 2022 and the ENETS Theranostics Task ForceVikas Prasad, Anna Koumarianou, Timm Denecke, et al.Frontiers in Oncology|January 27, 2022
Twenty Years On: RECIST as a Biomarker of Response in Solid Tumours an EORTC Imaging Group - ESOI Joint PaperLaure Fournier, Lioe-Fee de Geus-Oei, Daniele Regge, et al.European Journal of Nuclear Medicine and Molecular Imaging|January 12, 2021
International recommendations for personalised selective internal radiation therapy of primary and metastatic liver diseases with yttrium-90 resin microspheresHugo Levillain, Oreste Bagni, Christophe M Deroose, et al.Pageof 16